Accretive Health, Inc.·4

Jan 6, 4:05 PM ET

Accretive Health, Inc. 4

4 · Accretive Health, Inc. · Filed Jan 6, 2015

Insider Transaction Report

Form 4
Period: 2015-01-02
Nayden Denis
Director
Transactions
  • Award

    Director Stock Option (right to buy)

    2015-01-02$3.26/sh+4,598$14,9894,598 total
    Exercise: $6.55From: 2015-01-02Exp: 2025-01-02Common Stock (4,598 underlying)
Footnotes (1)
  • [F1]This option was issued to the reporting person pursuant to the Accretive Health director compensation plan in lieu of retainer fees of $15,000.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION